References:
1. Coronavirus Disease 2019 (COVID-19) Situation Report 124. 2020; https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200523-covid-19-sitrep-124.pdf?sfvrsn=9626d639_2, Accessed May 24, 2020.
2. Driggin E, Madhavan MV, Bikdeli B, Chuich T, Laracy J, Bondi-Zoccai G, Brown TS, Nigoghossian C, Zidar DA, Haythe J, Brodie D, Beckman JA, Kirtane AJ, Stone GW, Krumholz HM and Parikh SA. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll Cardiol . 2020.
3. Colson P, Rolain JM, Lagier JC, Brouqui P and Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents . 2020:105932.
4. Gao J, Tian Z and Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends . 2020;14:72-73.
5. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, Doudier B, Courjon J, Giordanengo V, Vieira VE, Dupont HT, Honore S, Colson P, Chabriere E, La Scola B, Rolain JM, Brouqui P and Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents . 2020:105949.
6. Szekely Y LY, Shrkihe BA, Bruck H, Oster HS, Viskin S. Chloroquine-induced torsade de pointes in a COVID-19 patient.Heart Rhythm . 2020.
7. Dower GE, Yakush A, Nazzal SB, Jutzy RV and Ruiz CE. Deriving the 12-lead electrocardiogram from four (EASI) electrodes. J Electrocardiol . 1988;21 Suppl:S182-7.
8. Ehlert FA, Goldberger JJ, Rosenthal JE and Kadish AH. Relation between QT and RR intervals during exercise testing in atrial fibrillation. Am J Cardiol . 1992;70:332-8.
9. Bland JM and Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet . 1986;1:307-10.
10. Cheung CC DB, Gibbs K, Laksma ZW, Krahn AD. Multi-lead QT Screening is Necessary for QT measurement: Implications for Management of Patients in the COVID-19 Era. JACC Clin Electrophysiol . 2020.
11. HRS COVID-19 Task Force Update: April 7, 2020. 2020.
12. Chang D, Saleh M, Gabriels J, Ismail H, Goldner B, Willner J, Beldner S, Mitra R, John R and Epstein LM. Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated with Hydroxychloroquine and/or Azithromycin. J Am Coll Cardiol . 2020.
13. Gabriels J, Saleh M, Chang D and Epstein LM. Inpatient use of mobile continuous telemetry for COVID-19 patients treated with hydroxychloroquine and azithromycin. HeartRhythm Case Rep . 2020.
14. Bekker CL, Noordergraaf F, Teerenstra S, Pop G and van den Bemt BJF. Diagnostic accuracy of a single-lead portable ECG device for measuring QTc prolongation. Ann Noninvasive Electrocardiol . 2020;25:e12683.
15. Janssen GH, Rijkenberg S and van der Voort PH. Validation of continuous QTc measurement in critically ill patients. J Electrocardiol . 2016;49:81-6.
16. Chenoweth JA, Hougham AM, Colby DK, Ford JB, Sandhu J, Albertson TE and Sutter ME. Monitoring the corrected QT in the acute care setting: A comparison of the 12lead ECG and bedside monitor. Am J Emerg Med . 2018;36:777-779.
17. Drew BJ, Adams MG, Pelter MM and Wung SF. ST segment monitoring with a derived 12-lead electrocardiogram is superior to routine cardiac care unit monitoring. Am J Crit Care . 1996;5:198-206.